Beone Medicines Ltd. Class A · SSE:688235

Oyler John sold 3,410 Beone Medicines Ltd. Class A shares (Form 4)

Traded Jun 23, 2026 · Filed Jun 25, 2026

On Jun 23, 2026, Oyler John (Director, Chief Executive Officer) sold 3,410 Beone Medicines Ltd. Class A shares at an average US$273.78 for US$934K, leaving 0 shares. Filed Jun 25, 2026 (Form 4).

Sold
3,410 shares
Price
US$273.78 average (US$273.30 to US$275.10)
Value
US$934K
Holding after
0 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 23, 2026American Depositary SharesSale1,800US$273.301,610Direct
Jun 23, 2026American Depositary SharesSale1,290US$274.12320Direct
Jun 23, 2026American Depositary SharesSale320US$275.100Direct

Source

View original at SEC

Related